Komodo Health (San Francisco, CA, USA) founded in 2014 is preparing for an initial public offering (IPO) this summer. Komodo Health, last valued at $3.3 billion, has hired banks for its upcoming IPO. The lead bookrunners are Goldman Sachs and SVB Securities according to Axios.
Komodo has created a ‘health care map,’ tracking patients during their clinical interactions to develop a clinical database of 330 million de-identified, real-world patient records. These data are now used by pharma companies for multiple use cases. The intention is to use the data to guide drug development plans, marketing strategies, and healthcare research. Thus, the predictive analytics opportunities exist for predicting barriers to clinical study success, understanding clinician influence, or accurately projecting treatment adherence.
Komodo's projected annual revenue is about $150 million, but it is not yet profitable.
Source: Axios
